| |
|
|
|
PLx Pharma Inc.  
|
|
4.85 0 (0%) |
02-19 16:00 |
|
Open: |
4.78 |
Pre close: |
4.85 |
Target:
|
6.19
|
|
High: |
4.9547 |
Low: |
4.74 |
Resistance:
|
5.30
6.44
|
|
Volume: |
12,601 |
Market Cap: |
42M |
Support:
|
3.45
2.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.09
 |
MACD |
MACD(12,26):
|
0.32 |
|
MA(20): |
5.23 |
Signal(12,26,9): |
0.46 |
|
MA(100): |
3.91  |
Stochastic Oscillator |
%K(14,3):
|
32.36 |
|
MA(250): |
4.14 |
%D(3): |
35.21 |
|
Average Volume(K) |
3-Month: |
5701
|
52-Week |
High:
|
6.90 |
|
10-Days: |
2315 |
Low: |
1.00 |
|
RSI |
RSI(14):
|
50.46 |
Change(%): |
-26.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.570 |
Return on Equity (ttm) |
-128.3 |
Shares Out. (M) |
8.75 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-34.8 |
Shares Float (M) |
4.28 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
-0.21 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
247.8 |
% Held by Institutions |
26.80 |
|
Forward EPS |
-1.350 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
13.640 |
EBITDA (p.s.) |
0.000 |
P/E |
-3.09 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.91 |
P/S |
471527744.00 |
|
Operating Margin |
-1545.34 |
Levered Free Cash Flow
(M) |
-9.78 |
P/CF |
-3.29 |
|
|
|
|
|
|
